| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378518 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378428 phosphodiesterase inhibitors; (Z)-2-(7-bromomethyl-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-(adamantan-1-yl)ethan-1-one; graft versus host disease, osteoporosis, bone fracture, restenosis, arteriosclerosis, obesity, ischemic reperfusion injury, depression, allergies, transplant rejection |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378274 Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2272063C Antithrombotic organic nitrates |
| 05/22/2008 | WO2008061247A2 Benzenesulfonanilide compound inhibitors of urea transporters |
| 05/22/2008 | WO2008061238A2 Processes for production of 4-biphenylyazetidin-2-ones |
| 05/22/2008 | WO2008060476A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/22/2008 | WO2008060372A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/22/2008 | WO2008060240A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| 05/22/2008 | WO2008059877A1 Aptamer against midkine and use thereof |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059513A2 Compounds suitable as modulators of hdl |
| 05/22/2008 | WO2008059024A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 05/22/2008 | WO2008058967A1 Organic compounds |
| 05/22/2008 | WO2008058641A1 Imidazo[2, 1-b]thiazoles and their use as pharmaceuticals |
| 05/22/2008 | WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058438A1 The use of ferric citrate in the manufacture of medicaments for treating blood vessel calcification |
| 05/22/2008 | WO2008058387A1 Renin inhibitors |
| 05/22/2008 | WO2008042968A3 Di-fluoro containing compounds as cysteine protease inhibitors |
| 05/22/2008 | WO2008027687A3 Use of tenecteplase for treating acute ischemic stroke |
| 05/22/2008 | WO2008023003A8 Drug combinations for treating airway diseases |
| 05/22/2008 | US20080119571 Transport proteins; lecithin-cholesterol acyltransferase; for increasing circulating high density lipoprotein cholesterol for treating atherosclerosis and related cardiovascular disorders |
| 05/22/2008 | US20080119561 Methods for preventing or delaying catheter- based resvascularization |
| 05/22/2008 | US20080119558 Drug for Inhibiting Production of Matrix Metalloprotease-9 |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119528 use of specific cyklolignans |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119509 Nontoxic; asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), eosinophilic granuloma, psoriasis |
| 05/22/2008 | US20080119495 Phosphodiesterase 4 inhibitors |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119476 Cetp Inhibitors |
| 05/22/2008 | US20080119474 5,6-bis(4-methoxyphenyl)-2-ethyl-2H-pyridazin-3-one; interleukin-1 beta antagonist; collagenase inhibitor; analgesic, antiinflammatory, antiarthritic, antiischemic agents; autoimmune disease, rheumatic diseases; osteoporosis |
| 05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
| 05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
| 05/22/2008 | US20080119460 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | US20080119438 medium molecular weight heparin ranging from 6,000 Daltons to 12,000 Daltons composition, has sufficient length to bridge antithrombin to thrombin, comprising a mixture of sulfated oligosaccharides; treating cardiovascular diseases, preventing the formation of a thrombus, arterial/deep vein thrombosis |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080119400 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/22/2008 | US20080118572 Methods and compositions for reducing the risk of adverse cardiovascular events associated with the administration of artificial blood |
| 05/22/2008 | US20080118560 Spray congealed 5-amido-7-benzyl(oxy or amino)imidazo[1,2-a]pyridines, at least one each of hydrophilic and hydrophobic matrix formers; antisecretory agents with improved water solubility, bioavailability and pharmacokinetics |
| 05/22/2008 | US20080118510 Vegf-related protein |
| 05/22/2008 | US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 05/22/2008 | US20080118499 Using concentration of golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) as diagnostic indicator of beta-site amyloid precursor protein cleaving enzyme (BACE) activity and prognostic tool for detection of cardiovascular, nervous sytem and cell proliferative disorders |
| 05/22/2008 | US20080118486 Using stem cell mixture comprising cluster of differentiation-34 proteins to generate cardiac tissue for treatment of myocardial infarction; tissue engineering; regenerative medicine |
| 05/22/2008 | US20080118481 Mononuclear phagocytes in therapeutic drug delivery |
| 05/22/2008 | US20080118435 Composition comprising low density microspheres |
| 05/22/2008 | CA2669969A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb3, hsdl2 and/or ldb2 |
| 05/22/2008 | CA2669867A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 05/22/2008 | CA2669670A1 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2669523A1 Aptamer against midkine and use thereof |
| 05/22/2008 | CA2669357A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | CA2668742A1 Renin inhibitors |
| 05/22/2008 | CA2668634A1 Organic compounds |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2666903A1 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923388A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/21/2008 | EP1923073A2 Combination medication comprising a PDE-5 inhibitor |
| 05/21/2008 | EP1923068A1 System and methods for opening obstructed biological conduits |
| 05/21/2008 | EP1923066A1 Composition comprising rooibos tea and conjugated linoleic acid (CLA) |
| 05/21/2008 | EP1923065A1 Cholesterol absorption inhibitor |
| 05/21/2008 | EP1923062A1 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals |
| 05/21/2008 | EP1922086A1 Targeted protein kinase c inhibitors and uses thereof |
| 05/21/2008 | EP1922073A1 New capped pyrazinoylguanidine sodium channel blockers |
| 05/21/2008 | EP1689410B1 Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol |
| 05/21/2008 | EP1603573B1 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 05/21/2008 | EP1603558B1 Process for preparation of perindopril and salts thereof |
| 05/21/2008 | EP1531791A4 Prevention and reduction of blood loss |
| 05/21/2008 | EP1517705B1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1326838B1 Novel crystalline forms of a factor xa inhibitor |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | EP1078002B1 Peptide antiangiogenic drugs |
| 05/21/2008 | CN201061615Y Ampule filled with injection |
| 05/21/2008 | CN101184757A Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 05/21/2008 | CN101184733A Novel piperidine carboxylic acid amide derivatives |
| 05/21/2008 | CN101184509A Agent for improvement of insulin resistance |
| 05/21/2008 | CN101184508A Methods of decreasing calcification |